VRCA
Verrica Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.11
-0.04 ▼ -0.65%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$6.11
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.61 | Insider Own | 94.04% | Shs Outstand | 0.02B | Perf Week | 15.07% |
| Market Cap | 0.10B | Forward P/E | - | EPS next Y | 48.33% | Insider Trans | 35.54% | Shs Float | 0.00B | Perf Month | 7.38% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | -0.42 | Inst Own | 28.87% | Short Float | 39.71% | Perf Quarter | -25.85% |
| Income | -0.02B | P/S | 2.95 | EPS this Y | 13.99% | Inst Trans | 33.01% | Short Ratio | 2.49 | Perf Half Y | 23.68% |
| Sales | 0.04B | P/B | 4.24 | EPS next 5Y | - | ROA | -35.02% | Short Interest | 0.41M | Perf YTD | -26.47% |
| Book/sh | 1.44 | P/C | 3.48 | EPS past 3/5Y | 38.35% 37.12% | ROE | -240.35% | 52W High | -37.79% ($9.82) | Perf Year | 3.37% |
| Cash/sh | 1.76 | P/FCF | - | Sales past 3/5Y | 57.93% - | ROIC | -69.79% | 52W Low | 86.28% ($3.28) | Perf 3Y | -90.56% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 89.54% | Gross Margin | 90.33% | Volatility(W/M) | 15.01% 9.22% | Perf 5Y | -96.39% |
| Dividend TTM | - | EV/Sales | 2.15 | Sales Y/Y TTM | 370.22% | Oper. Margin | -33.56% | ATR (14) | 0.54 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.33 | EPS Q/Q | 76.22% | Profit Margin | -50.27% | RSI (14) | 51.77 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.47 | Sales Q/Q | 1380.23% | SMA20 | 7.59% ($5.68) | Beta | 1.39 | Target Price | $18.67 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 3000000 | SMA50 | -9.27% ($6.73) | Rel Volume | 0.54 | Prev Close | $6.15 |
| Employees | 76 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | 22.13% 12.65% | SMA200 | 1.53% ($6.02) | Avg Volume(3M) | 0.16M | Price | $6.11 |
| IPO | 2018/6/15 | Option/Short | No/Yes | Trades | 1404 | Volume | 87,818 | Change | -0.65% |
뉴스 로딩 중...